Endocrine and other factor-regulated calcium reabsorption
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H05 CALCIUM HOMEOSTASIS
H05A PARATHYROID HORMONES AND ANALOGUES
H05AA Parathyroid hormones and analogues
H05AA04 Abaloparatide
D11563 Abaloparatide acetate (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
243 Thyroid and parathyroid hormone preparations
2439 Others
D11563 Abaloparatide acetate (JAN)
Drug groups [BR:br08330]
Hormonal agent
DG01661 Parathyroid hormone and parathyroid hormone-related protein analog
DG03050 Abaloparatide
D11563 Abaloparatide acetate
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG03050 Abaloparatide
D11563 Abaloparatide acetate
Drug classes [BR:br08332]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
D11563 Abaloparatide acetate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Parathyroid hormone
PTH1R
D11563 Abaloparatide acetate (JAN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11563
Drug groups [BR:br08330]
Hormonal agent
DG01661 Parathyroid hormone and parathyroid hormone-related protein analog
DG03050 Abaloparatide
Musculo-skeletal system agent
DG03232 Osteoporosis agent
DG03050 Abaloparatide
